ZFAS1 and hepatocellular carcinoma: Leng et al. [51] (n = 820) identified amplified OS risk in gastrointestinal malignancies containing HCC (HR = 2.03 vs overall HR = 1.97), suggesting tissue-specific microenvironmental modulation of ZFAS1's prognostic value.